Both in Pharmaceuticals
Eli Lilly & vs Bristol-Myers Squibb
Over the past year LLY returned +57.4% and BMY returned +36.9%; their daily moves had a correlation of 0.42.
LLY +57.4% BMY +36.9%Growth of $1, one year, split-adjusted
| Metric | LLY | BMY |
|---|---|---|
| Price | $1,410.99 | $63.02 |
| Market cap | $1.26T | $128.82B |
| Today | −0.46% | +0.86% |
| 1 month | +23.5% | +3.1% |
| 6 months | +45.8% | +9.8% |
| Year to date | +31.3% | +16.8% |
| 1 year | +67.1% | +38.1% |
| Revenue growth (YoY) | +38.6% | +5.7% |
| Gross margin | 83.9% | 71.3% |
| Net margin | 26.4% | 25.6% |
| P/E (TTM) | 45.6× | 13.9× |
| Price / sales | 14.5× | 2.6× |
| Net cash | -$44.62B | -$32.05B |
| Dividend yield | 0.49% | 4.00% |
| Volatility (60d) | 30.8% | 27.3% |
| Short % of float | 0.8% | 2.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).